- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 239
Stanford's Annexon annexes $75m
Immunotherapy spinout Annexon Biosciences collected funding from Novartis Venture Fund in a series C round that brought its total funding to $154m.
Dec 21, 2018ACV Auctions wins $93m
The Softbank-backed online automotive marketplace has collected $93m in a Bain Capital-led round to take its total equity financing to $145m.
Dec 21, 2018The Wing glides into $75m series C
Airbnb and WeWork both backed the female-only space provider's series C round, bringing its overall funding to more than $117m.
Dec 21, 2018Entrada darts to $59m series A round
MRL Ventures Fund and Roche Fund have taken part in the intracellular drug developer's series A, which is commercialising research by Prof Dehua Pei at OSU.
Dec 20, 2018Synspective receives $2.7m boost
Synspective has been backed by a University of Tokyo VC vehicle in its bid to launch a constellation of 25 small Earth observation satellites powered by synthetic aperture radar.
Dec 20, 2018Entrada darts to $59m series A round
MRL Ventures Fund and Roche Fund have taken part in the intracellular drug developer's series A round, which will fund clinical trials of its lead program.
Dec 20, 2018VoxelCloud passes series B test with $50m
Tencent-backed medical diagnostics technology developer VoxelCloud has now raised $78.5m in total, Shenzhen Hongtai Capital Management having led its latest round.
Dec 19, 2018Yunding locks up $87m series D
Baidu has led a series D round for the smart device maker, whose existing investors reportedly include Fosun, Legend Star, Xiaomi and Red Star Macalline.
Dec 19, 2018Fuji Pharma fuels Alvotech with $50m
Biosimilar developer Alvotech has received $50m from Fuji Pharma through a development and commercialisation deal, valuing it at $1.19bn.
Dec 19, 2018AC Immune accepts $50m from Eli Lilly
The drug developer has received the convertible note financing from Eli Lilly as part of a licence and collaboration deal that could reach $190m.
Dec 18, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


